TYVASO DPI IS NOW APPROVED

Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Skip to main content

REQUEST A REP

Thank you for your interest in TYVASO. We’re here to help.

To have a United Therapeutics Cardiopulmonary Specialist contact you about TYVASO for PH-ILD, please fill out the form below and click Submit.

*Required Field

Privacy

United Therapeutics respects your right to have your personal information kept private. We may use this information to send you materials on our products and services that may be of interest to you. We will not share your information with any third parties or outside mailing lists.

Clicking the Submit button signifies that you have read and agree to our Privacy Policy, and that you agree to receive future communications from TYVASOhcp.com or United Therapeutics Corporation.